BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34143891)

  • 1. RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Fakhry C; Tewari SR; Zhang L; Windon MJ; Bigelow EO; Drake VE; Rooper LM; Troy T; Ha P; Miles BA; Mydlarz WK; Eisele DW; D'Souza G
    Cancer; 2021 Oct; 127(19):3523-3530. PubMed ID: 34143891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
    Fakhry C; Zhang Q; Gillison ML; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Yom SS; Wong SJ; Ridge JA; Rao SSD; Spencer S; Fortin A; Raben D; Harris J; Le QT
    Cancer; 2019 Jun; 125(12):2027-2038. PubMed ID: 30913305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
    Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
    Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
    Gillison ML; Zhang Q; Jordan R; Xiao W; Westra WH; Trotti A; Spencer S; Harris J; Chung CH; Ang KK
    J Clin Oncol; 2012 Jun; 30(17):2102-11. PubMed ID: 22565003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.
    Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN
    Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
    Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
    Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
    Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early
    Mowery YM; Vergalasova I; Rushing CN; Choudhury KR; Niedzwiecki D; Wu Q; Yoo DS; Das S; Wong TZ; Brizel DM
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):969-976. PubMed ID: 32800802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
    Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
    JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The Added Value of Prognostic Models in the New TNM 8th Edition Era.
    Deschuymer S; Dok R; Laenen A; Hauben E; Nuyts S
    Front Oncol; 2018; 8():273. PubMed ID: 30083517
    [No Abstract]   [Full Text] [Related]  

  • 19. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
    Ma SJ; Yu H; Khan M; Yu B; Santhosh S; Chatterjee U; Gill J; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
    Oral Oncol; 2022 Oct; 133():106054. PubMed ID: 35933937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Lassen P; Huang SH; Su J; Waldron J; Andersen M; Primdahl H; Johansen J; Kristensen CA; Andersen E; Eriksen JG; Hansen CR; Alsner J; Lilja-Fisher J; Bratman SV; Ringash J; Kim J; Hope A; Spreafico A; de Almeida J; Xu W; O'Sullivan B; Overgaard J
    Int J Cancer; 2022 Apr; 150(8):1329-1340. PubMed ID: 34792199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.